Etiology and Management of Lack or Loss of Response to Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease

  Abstract: The management of patients with moderate to severe inflammatory bowel disease was transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a […]

Overview of Therapeutic Drug Monitoring of Biologic Agents in Patients With Inflammatory Bowel Disease

  G&H  What is the goal of therapeutic drug monitoring? AC  From my perspective, the goal of therapeutic drug monitoring (TDM) is to optimize the care […]

Millennium Medical Publishing, Inc